Motor neuron disease: a chemical perspective

J Med Chem. 2014 Aug 14;57(15):6316-31. doi: 10.1021/jm5001584. Epub 2014 Apr 17.

Abstract

This Perspective provides a background to the pathogenesis of neurodegenerative disease and specifically amyotrophic lateral sclerosis (ALS) and gives an overview of the many pathways, both genetically inheritable and sporadic, that may lead to the premature activation of apoptotic pathways in neurons, as well as current and proposed approaches toward interrupting these pathways.

Publication types

  • Review

MeSH terms

  • Amino Acid Transport System X-AG / metabolism
  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Amyotrophic Lateral Sclerosis / genetics
  • Amyotrophic Lateral Sclerosis / metabolism
  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Apoptosis
  • Disease Models, Animal
  • Genetic Therapy
  • Glutamic Acid / metabolism
  • Humans
  • Mice, Transgenic
  • Mitochondria / metabolism
  • Mutation
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Reactive Oxygen Species / metabolism
  • Receptors, Glutamate / metabolism
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism
  • Superoxide Dismutase-1

Substances

  • Amino Acid Transport System X-AG
  • Antioxidants
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • Receptors, Glutamate
  • SOD1 protein, human
  • Glutamic Acid
  • Sod1 protein, mouse
  • Superoxide Dismutase
  • Superoxide Dismutase-1